Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details)

v3.20.1
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 23, 2019
Dec. 11, 2019
Dec. 05, 2019
Dec. 05, 2019
Nov. 20, 2019
Nov. 11, 2019
Sep. 30, 2019
Sep. 25, 2019
Sep. 16, 2019
Sep. 09, 2019
Jul. 17, 2019
Feb. 13, 2019
Feb. 01, 2019
Jan. 30, 2019
Apr. 30, 2020
Jun. 28, 2019
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Oct. 26, 2019
Dec. 19, 2018
Stockholders' Equity (Details) [Line Items]                                          
Common stock authorized shares                         45,000,000         45,000,000 45,000,000    
Common stock per share (in Dollars per share)                                   $ 0.001 $ 0.001    
Convertible shares value (in Dollars)                                   $ 2,092,445    
Common Stock, Conversion Basis                                   On or about February 1, 2019, the Company’s founder and CEO as well as another shareholder transferred an aggregate of approximately 1,379,000 and 144,000 shares of common stock, respectively to certain consultants of the Company, of which approximately 983,000 and 144,000 shares of common stock, respectively were sold to consultants in exchange for promissory notes.      
Expected life                       10 years 5 years                
Risk-free interest rate                       0.25% 2.51%           2.41%    
Volatility                       90.00% 92.00%           91.95%    
Dividend yield                       0.00% 0.00%                
Stock-based compensation expense (in Dollars)                               $ 162,250          
Common stock transferred                                   396,000      
Shares Issued, Price Per Share (in Dollars per share)                                   $ 4.37      
Stock-based compensation expense (in Dollars)                                   $ 7,482,254    
Granted shares                       425,000                  
Stockholders’ Equity description     Additionally, on December 10, 2019, the board of directors awarded stock options under the 2016 Plan to each of the three remaining independent directors to 50,000 shares of the Company’s common stock. The stock options have a term of five years, an exercise price of $2.64 per share, vest immediately on the grant date of December 10, 2019 and had a grant date fair value of $388,746. The Company determined the fair value of the stock options using the Black-Scholes model with the following inputs: expected life 10 years, risk-free interest rate 1.0%, dividend yield 0% and expected volatility 100%.                                    
Unrecognized expense (in Dollars)                                   $ 3,200,000 $ 0    
Share-based Payment Arrangement, Tranche One [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Granted shares                       525,000                  
2016 Stock Option Plan [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Common stock issuance                           3,000,000              
2016 Equity Incentive Plan [Member                                          
Stockholders' Equity (Details) [Line Items]                                          
Fair value (in Dollars)                       $ 2,700,000                  
Aggregate shares                       53,572                  
Exercise price (in Dollars per share)                       $ 6.49                  
Fair value (in Dollars)                       $ 431,000                  
RSU’s [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Convertible shares value (in Dollars)     $ 135,000                                    
Common stock issuance     50,000                                    
Shares received by employees                                       250,000  
Consultants [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Stock-based compensation expense (in Dollars)                                 $ 1,700,000        
Subsequent Event [Member] | Employee [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Shares cancelled                             225,000            
Series A Convertible Preferred Stock [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Shares issued 9,211 6,579       200,000   73,156 43,081 200,000 65,789                    
Conversion of shares                 16,371 76,000 25,000                    
Convertible shares value (in Dollars) $ 26,343 $ 21,053       $ 584,000   $ 250,000                          
Series A Convertible Preferred Stock One [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Shares issued                 108,422                        
Conversion of shares                 41,200                        
Series A Preferred Stock [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Preferred stock authorized                                   900,000 900,000   900,000
Preferred stock par value (in Dollars per share)                                   $ 0.001 $ 0.001   $ 0.001
Former Employee [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Shares issued         25,000   24,843                            
Convertible shares value (in Dollars)         $ 73,250   $ 75,000                            
Director [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Shares issued       50,000                                  
Convertible shares value (in Dollars)       $ 135,000                                  
Chief Executive Officer [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Stock-based compensation expense (in Dollars)                                 $ 3,600,000        
Management [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Granted shares                       325,000                  
Management [Member] | Share-based Payment Arrangement, Tranche One [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Granted shares                       225,000                  
Consultants [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Granted shares                       100,000                  
Consultants [Member] | Share-based Payment Arrangement, Tranche One [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Granted shares                       300,000                  
Employee [Member] | 2016 Equity Incentive Plan [Member                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate shares                       25,000